Sembra che tu risieda in United States ma il sito che hai attualmente selezionato per visitarci รจ Italy. Vuoi cambiare sito?

Si, grazie! No desidero rimanere in questo sito

Enable high contrast mode

Xylem Reports First Quarter Results

First-Quarter Highlights

  • Orders of $2.2 billion, up 3% on a reported basis and flat organically
  • Revenue of $2.1 billion, up 3% on a reported basis and flat organically
  • Earnings per share of $0.79, up 14%; $1.12 on an adjusted basis, up 9%

Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the worldโ€™s most challenging water issues, today reported first-quarter 2026 results. The Company delivered total revenue of $2.1 billion, on strong execution. First-quarter earnings per share were up 14 percent on a reported basis and 9 percent on an adjusted basis.

โ€œWe entered the year with sustained momentum and solid demand across key end markets,โ€ said Matthew Pine, Xylemโ€™s CEO. โ€œWhile the external environment remains dynamic, our teams are executing well, staying close to customers, and advancing long-term priorities.โ€ Pine added, โ€œOur steady progress this quarter demonstrates that our multi-year operating transformation is gaining traction, with disciplined execution and operational rigor.โ€

Net income attributable to Xylem for the quarter was $193 million, or $0.79 per share. Net income margin increased 90 basis points to 9.1 percent. These results are driven by strong operational performance and a reduction in the estimated loss on sale of businesses, partially offset by increased restructuring and realignment costs. Adjusted net income attributable to Xylem was $272 million, or $1.12 per share, which excludes the loss on sale of businesses, purchase accounting intangible amortization, restructuring and realignment costs, and special charges.

First-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 20.6 percent, reflecting a year-over-year increase of 20 basis points. Productivity savings and strong price realization drove the margin expansion, exceeding the impact of inflation, mix, and lower volumes.

Outlook

Xylem now forecasts full-year 2026 revenue of approximately $9.2 to $9.3 billion, up approximately 2 to 3 percent on a reported basis, versus 1 to 3 percent previously guided, and up approximately 2 to 4 percent on an organic basis, as previously guided.

Full-year 2026 adjusted EBITDA margin is expected to be approximately 22.9 to 23.3 percent, an increase of 70 to 110 basis points from Xylemโ€™s 2025 adjusted results. This results in full-year adjusted earnings per share of $5.35 to $5.60, in line with the previous guidance range. Full-year free cash flow margin is still expected to be approximately 10.2 to 11.0 percent.

Further 2026 planning assumptions are included in Xylemโ€™s first-quarter 2026 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Supplemental information on Xylemโ€™s first-quarter earnings, as well as definitions of and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Letโ€™s Solve Water.

Xylem uses our Investor Relations website, www.xylem.com/en-us/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts, and social media.

Forward-Looking Statements

This press release contains โ€œforward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words โ€œanticipate,โ€ โ€œestimate,โ€ โ€œexpect,โ€ โ€œproject,โ€ โ€œintend,โ€ โ€œplan,โ€ "contemplate," "predict," โ€œforecast,โ€ โ€œlikely,โ€ โ€œbelieve,โ€ โ€œtarget,โ€ โ€œgoal,โ€ โ€œobjective,โ€ โ€œwill,โ€ โ€œcould,โ€ โ€œwould,โ€ โ€œshould,โ€ "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, availability of funding for our customers, inflation and governmentsโ€™ related monetary policy in response, and the strength of the real estate markets, on economic activity and our operations; geopolitical matters, including nationalism, protectionism and anti-global sentiment, volatility involving the U.S. and other governments, ongoing, escalation or outbreak of international conflicts, and regulatory, trade protection, economic and other risks associated with our global sales and operations; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, labor shortages, trade agreements, tariffs, and other trade protection measures, and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents, data breaches, or other disruptions of information technology systems on which we or our customers rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including semiconductors or other key components; operational disruptions at our facilities or that of third parties upon which we rely; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including as respects performance guarantees and customersโ€™ budgets, timelines and safety requirements; our ability to retain, compete for and attract leadership, other key talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around productivity, simplification, restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, volatile weather events, or changing climate patterns; risks related to our sustainability efforts and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; failure to comply with, or changes in, laws or regulations, pertaining to our business conduct, operations, products and services, including anti-corruption, artificial intelligence, data privacy and security, trade, competition, the environment, and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under โ€œItem 1A. Risk Factorsโ€ in our Annual Report on Form 10-K for the year ended December 31, 2025 and in subsequent filings we make with the Securities and Exchange Commission (โ€œSECโ€).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC or other regulatory authorities, and are not intended to create legal rights or obligations. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on: standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.

All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

For the three months ended March 31,

2026

2025

Revenue from products

$

1,757

$

1,709

Revenue from services

368

360

Revenue

2,125

2,069

Cost of revenue from products

1,057

1,041

Cost of revenue from services

265

260

Cost of revenue

1,322

1,301

Gross profit

803

768

Selling, general and administrative expenses

472

460

Research and development expenses

56

56

Restructuring and asset impairment charges

31

21

Operating income

244

231

Interest expense

(4

)

(8

)

Other non-operating income, net

โ€”

4

Gain/(Loss) on sale of businesses

4

(10

)

Income before taxes

244

217

Income tax expense

(55

)

(50

)

Net income

$

189

$

167

Net loss attributable to non-controlling interests

4

2

Net income attributable to Xylem

$

193

$

169

Earnings per share:

Basic

$

0.79

$

0.69

Diluted

$

0.79

$

0.69

Weighted average number of shares:

Basic

242.8

243.1

Diluted

243.4

243.8

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions)

March 31,
2026

December 31,
2025

ASSETS

Current assets:

Cash and cash equivalents

$

808

$

1,479

Receivables, less allowances for discounts, returns and credit losses of $53 and $68 in 2026 and 2025, respectively

1,796

1,759

Inventories

991

983

Prepaid and other current assets

243

244

Assets held for sale

192

176

Total current assets

4,030

4,641

Property, plant and equipment, net

1,151

1,159

Goodwill

8,292

8,332

Other intangible assets, net

2,213

2,272

Other non-current assets

1,268

1,230

Total assets

$

16,954

$

17,634

LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND STOCKHOLDERSโ€™ EQUITY

Current liabilities:

Accounts payable

$

969

$

1,013

Accrued and other current liabilities

1,182

1,237

Short-term borrowings and current maturities of long-term debt

531

534

Liabilities held for sale

73

72

Total current liabilities

2,755

2,856

Long-term debt

1,407

1,408

Accrued post-retirement benefit obligations

308

317

Deferred income tax liabilities

437

405

Other non-current accrued liabilities

818

899

Total liabilities

5,725

5,885

Redeemable non-controlling interest

249

258

Stockholdersโ€™ equity:

Common stock โ€“ par value $0.01 per share:

Authorized 750.0 shares, issued 260.3 shares and 259.9 shares in 2026 and 2025, respectively

3

3

Capital in excess of par value

8,772

8,759

Retained earnings

3,794

3,706

Treasury stock โ€“ at cost 21.2 shares and 16.3 shares in 2026 and 2025, respectively

(1,368

)

(768

)

Accumulated other comprehensive loss

(229

)

(220

)

Total stockholdersโ€™ equity

10,972

11,480

Non-controlling interests

8

11

Total equity

10,980

11,491

Total liabilities, redeemable non-controlling interest, and stockholdersโ€™ equity

$

16,954

$

17,634

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)

For the three months ended March 31,

2026

2025

Operating Activities

Net income

$

189

$

169

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

65

68

Amortization

75

77

Share-based compensation

13

12

Restructuring and asset impairment charges

31

21

(Gain) Loss from sale of businesses

(4

)

10

Other, net

(8

)

11

Payments for restructuring

(37

)

(21

)

Changes in assets and liabilities (net of acquisitions):

Changes in receivables

(58

)

(48

)

Changes in inventories

(18

)

(9

)

Changes in accounts payable

(61

)

(64

)

Changes in long term receivables

(31

)

(32

)

Other, net

(48

)

(161

)

Net Cash โ€“ Operating activities

108

33

Investing Activities

Capital expenditures

(90

)

(71

)

Acquisitions of businesses, net of cash acquired

โ€”

(7

)

Proceeds from sale of businesses, net of cash disposed

โ€”

48

Proceeds from the sale of property, plant and equipment

1

5

Cash paid for investments

โ€”

(1

)

Cash paid for asset acquisition

(1

)

โ€”

Cash received from cross-currency swaps

14

12

Other, net

โ€”

(1

)

Net Cash โ€“ Investing activities

(76

)

(15

)

Financing Activities

Short-term debt issued, net

โ€”

1

Long-term debt repaid

(4

)

(4

)

Repurchase of common stock

(563

)

(13

)

Proceeds from exercise of employee stock options

โ€”

6

Dividends paid

(106

)

(98

)

Other, net

(10

)

(8

)

Net Cash โ€“ Financing activities

(683

)

(116

)

Effect of exchange rate changes on cash

(15

)

25

Increase in cash classified within assets held for sale

(5

)

โ€”

Decrease in cash classified within assets held for sale

โ€”

11

Changes in cash classified within assets held for sale

(5

)

11

Net change in cash and cash equivalents

(671

)

(62

)

Cash and cash equivalents at beginning of year

1,479

1,121

Cash and cash equivalents at end of period

$

808

$

1,059

Supplemental disclosure of cash flow information:

Cash paid during the period for:

Interest

$

11

$

12

Income taxes (net of refunds received)

$

28

$

37

Xylem Inc. Non-GAAP Measures
Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.
โ€œOrganic revenue" and "Organic ordersโ€ defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.
โ€œEBITDAโ€ defined as earnings before interest, taxes, depreciation and amortization expense.โ€œAdjusted EBITDAโ€ and"Adjusted Segment EBITDA"reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.
"Adjusted EBITDA Margin" and"Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.
"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and โ€œAdjusted EPSโ€ defined as operating income, segment operating income, net income attributable to Xylem and earnings per share attributable to Xylem, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.
"Adjusted Operating Margin" and"Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.
โ€œFree Cash Flowโ€ defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures. Our definition of free cash flow does not consider certain non-discretionary cash payments, such as debt.
"Free Cash Flow Margin"defined as free cash flow, adjusted (as applicable) for significant cash paid or received for non-operational tax, acquisition or divestiture activities; divided by revenue.
โ€œRealignment costsโ€defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
โ€œSpecial charges"defined as non-recurring costs incurred by the Company, such as those related to acquisitions and integrations, divestitures and non-cash impairment charges.
โ€œTax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic ($ Millions)

(As Reported - GAAP)

(As Adjusted - Organic)

(A)

(B)

(C)

(D)

(E)

(F) = B+C+D+E

(G) = F/(A-D)

Change

% Change

Acquisitions

Divestitures

Change

% Change

Orders

Orders

2026 v. 2025

2026 v. 2025

Book-to-Bill

FX Impact

Adj. 2026 v. 2025

Adj. 2026 v. 2025

2026

2025

Quarter Ended March 31
Xylem Inc.

2,228

2,158

70

3

%

105

%

(12

)

5

(70

)

(7

)

0

%

Water Infrastructure

675

626

49

8

%

112

%

(8

)

5

(32

)

14

2

%

Applied Water

512

486

26

5

%

114

%

-

-

(15

)

11

2

%

Measurement and Control Solutions

475

402

73

18

%

94

%

-

-

(11

)

62

15

%

Water Solutions and Services

566

644

(78

)

(12

%)

100

%

(4

)

-

(12

)

(94

)

(15

%)

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic ($ Millions)

(As Reported - GAAP)

(As Adjusted - Organic)

(A)

(B)

(C)

(D)

(E)

(F) = B+C+D+E

(G) = F/(A-D)

Change

% Change

Acquisitions

Divestitures

Change

% Change

Revenue

Revenue

2026 v. 2025

2026 v. 2025

FX Impact

Adj. 2026 v. 2025

Adj. 2026 v. 2025

2026

2025

Quarter Ended March 31
Xylem Inc.

2,125

2,069

56

3

%

(5

)

5

(65

)

(9

)

0

%

Water Infrastructure

603

581

22

4

%

(3

)

5

(29

)

(5

)

(1

%)

Applied Water

448

435

13

3

%

-

-

(14

)

(1

)

0

%

Measurement and Control Solutions

508

490

18

4

%

-

-

(11

)

7

(1

%)

Water Solutions and Services

566

563

3

1

%

(2

)

-

(11

)

(10

)

(2

%)

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
Q1 2026Q1 2025
As ReportedAdjustmentsAdjustedAs ReportedAdjustmentsAdjusted
Total Revenue

2,125

-

2,125

2,069

-

2,069

Operating Income

244

98

a

342

231

94

a

325

Operating Margin

11.5

%

16.1

%

11.2

%

15.7

%

Interest Expense

(4

)

-

(4

)

(8

)

-

(8

)

Other Non-Operating Income (Expense)

-

5

b

5

4

-

4

Gain/(Loss) From Sale of Businesses

4

(4

)

c

-

(10

)

10

c

-

Income before Taxes

244

99

343

217

104

321

Provision for Income Taxes

(55

)

(20

)

d

(75

)

(50

)

(22

)

d

(72

)

Net Income

189

79

268

167

82

249

Net Loss Attributable to Non-controlling Interests

4

-

4

2

-

2

Net Income Attributable to Xylem

193

79

272

169

82

251

Diluted Shares

243.4

243.4

243.8

243.8

Diluted EPS

$

0.79

$

0.33

$

1.12

$

0.69

$

0.34

$

1.03

a

Restructuring & realignment costs: 2026 - $38 million; 2025 - $27 million

Special charges: 2026 - $5 million of acquisition, divestiture & integration costs; 2025 - $8 million of acquisition, divestiture & integration costs and $4 million of intangible asset impairment charges

Purchase accounting intangible amortization: 2026 - $55 million; 2025 - $55 million

b

Other special charges

c

Gain/(Loss) from sale of businesses as per income statement for all periods presented

d

2026 - Net tax impact on pre-tax adjustments (notes a, b and c) of $21 million and $1 million of other tax special expense items; 2025 - Net tax impact on pre-tax adjustments (note a and b) of $22 million

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)

2026

Q1Q2Q3Q4Total
Net Income attributable to Xylem

193

193

Net Income margin

9.1

%

9.1

%

Depreciation

65

65

Amortization

75

75

Interest Expense (Income), net

(4

)

(4

)

Income Tax Expense

55

55

EBITDA

384

384

Share-based Compensation

13

13

Restructuring & Realignment

38

38

Special Charges

10

10

Loss/(Gain) from sale of businesses

(4

)

(4

)

Loss attributable to non-controlling interest

(4

)

(4

)

Adjusted EBITDA

437

437

Revenue

2,125

2,125

Adjusted EBITDA Margin

20.6

%

20.6

%

2025

Q1Q2Q3Q4Total
Net Income attributable to Xylem

169

226

227

335

957

Net Income margin

8.2

%

9.8

%

10.0

%

14.0

%

10.6

%

Depreciation

68

69

64

66

267

Amortization

77

76

78

77

308

Interest Expense (Income), net

-

3

-

(1

)

2

Income Tax Expense

50

75

71

35

231

EBITDA

364

449

440

512

1,765

Share-based Compensation

12

13

12

16

53

Restructuring & Realignment

27

29

30

45

131

Special Charges

12

13

9

2

36

Loss/(Gain) from sale of businesses

10

-

37

(16

)

31

Loss attributable to non-controlling interest

(2

)

(2

)

(1

)

(2

)

(7

)

Adjusted EBITDA

423

502

527

557

2,009

Revenue

2,069

2,301

2,268

2,397

9,035

Adjusted EBITDA Margin

20.4

%

21.8

%

23.2

%

23.2

%

22.2

%

Media
Press Office
+1 (978) 704-5149
PressOffice@xylem.com

Investors
Michael Travers
+1 (724) 772-1597
Michael.Travers@xylem.com

Source: Xylem Inc.
Xylem